Anencephaly: Neural Tube Defect Insights

Anencephaly represents one of the most severe and lethal congenital malformations encountered in human embryology, characterized by the catastrophic failure of the anterior neural tube to close during early gestational development. This fatal developmental defect deprives the developing fetus of the major portions of the brain, skull vault, and scalp, posing profound diagnostic, clinical, and ethical challenges for obstetricians, pediatricians, and bioethicists alike. Understanding its biological mechanisms, diagnostic milestones, preventive measures, and complex socio-cultural dimensions remains crucial for modern maternal-fetal medicine and reproductive public health.

Anencephaly

1. Concise Definition

Anencephaly is a lethal congenital malformation characterized by the total or partial absence of the cranial vault (calvaria), scalp, and cerebral hemispheres, accompanied by a rudimentary brainstem and exposed neurovasculosa. It occurs when the rostral (anterior) neuropore fails to close during the third to fourth week of human embryogenesis, typically between gestational days 24 and 26. The condition is universally fatal, resulting in stillbirth or neonatal demise within hours or days following birth.

As an open neural tube defect (NTD), anencephaly results from secondary degeneration of embryonic nervous tissue exposed directly to amniotic fluid. Although the rudimentary diencephalon and brainstem may partially develop, the telencephalon and overlying mesodermal skeletal structures fail to differentiate and ossify. Consequently, neonates with anencephaly retain basic autonomic functions such as spontaneous cardiac contractions and brainstem reflexes, but permanently lack higher cortical processing, cognitive function, sensory awareness, and consciousness.

The malformation presents significant implications across maternal health, reproductive genetics, and prenatal care. While secondary preventive efforts—such as maternal periconceptional supplementation with folic acid—have significantly reduced global prevalence rates, anencephaly remains a prominent focus of modern teratology, epidemiology, and pediatric bioethics.

2. Etymology and Linguistic Origin

The term anencephaly is derived from the Classical Greek prefix an- (ἀν-), denoting negation, privation, or absence (“without”), combined with the Greek root enkephalos (ἐγκέφαλος), meaning “brain” or literally “that which is inside the head” (from en, “in”, and kephalē, “head”). The nominal suffix -y designates a state, quality, or medical condition.

Although the literal etymological interpretation suggests an individual “without a brain,” the condition is technically a misnomer in strictly morphological terms. Affected individuals invariably retain a disorganized, highly vascularized neuroepithelial mass known as the area cerebrovasculosa, along with varying portions of the midbrain, medulla oblongata, and cerebellum. The term entered modern biomedical vocabulary during the eighteenth and nineteenth centuries, gaining systematic classification through the seminal embryological treatises of French anatomists Étienne Geoffroy Saint-Hilaire and Isidore Geoffroy Saint-Hilaire, who cataloged cranial abnormalities within the fledgling science of teratology.

3. Pronunciation and Grammatical Form

In standard English phonology, the noun is pronounced as /ˌæn.ɛnˈsɛf.ə.li/ in American English and /ˌæn.ɛnˈkɛf.ə.li/ or /ˌæn.ɛnˈsɛf.ə.li/ in British medical English. The principal stress rests on the third syllable (“sef”).

Grammatically, the term functions as an uncountable, non-collective medical noun:

• Noun (Condition): Anencephaly (e.g., “The routine second-trimester ultrasound confirmed a diagnosis of anencephaly.”)
• Adjective: Anencephalic (/ˌæn.ɛn.səˈfæl.ɪk/) (e.g., “Anencephalic infants exhibit rudimentary auditory and vestibular brainstem reflexes.”)
• Noun (Individual): Anencephalic (occasionally used to denote an infant born with the condition, though person-first clinical terminology such as “infant with anencephaly” is preferred in modern pediatric ethics).
• Variant / Related Terms: Anencephalus (Latinate morphological singular, common in early twentieth-century pathological literature), exencephaly (the transient pre-degenerative embryonic state).

4. Detailed Conceptual Explanation

To grasp the full conceptual framework of anencephaly, one must examine primary and secondary neurulation. During the third week of human post-fertilization development, the flat neural plate undergoes longitudinal folding, generating the neural groove bordered by two elevated neural folds. These folds progressively approximate and fuse along the dorsal midline. Fusion begins in the region corresponding to the future hindbrain and proceeds simultaneously in both rostral and caudal directions, culminating in the closure of the anterior neuropore by embryonic day 24 to 26.

When the anterior neuropore fails to meet and seal, the developmental cascade responsible for cranial neurocranium formation is permanently interrupted. The embryonic brain, initially formed as an exposed, uncovered mass termed exencephaly, remains vulnerable to the mechanical stresses of uterine life and the biochemical hostility of the surrounding amniotic fluid. Amniotic fluid contains enzymes, fetal urine, and metabolic waste products that progressively macerate, necrotize, and dissolve the exposed neuroepithelium throughout the second and third trimesters.

By the time of delivery, the cerebral hemispheres have regressed into a disorganized hemorrhagic sponge composed of glial cells, connective tissue, angiomatous vascular channels, and choroid plexus fragments. The neurocranium—specifically the frontal, parietal, and occipital bones superior to the skull base—is entirely absent. This produces the distinctive phenotypic appearance characterized by protruding, shallow orbits, flattened facies, prominent proptosis, an absent forehead, and a continuous transition from the base of the skull into the upper cervical vertebrae.

Because the brainstem and spinal cord are often anatomically spared or only partially disrupted, the vital vegetative centers controlling heart rate, respiration, and thermoregulation can function transiently after birth. Anencephalic newborns frequently display sucking, rooting, swallowing, and withdrawal reflexes. However, because neocortical integration is neuroanatomically impossible, these movements are purely non-cognitive, involuntary reflex arcs. Sensory processing, environmental awareness, distress perception, and sustained voluntary motor activity cannot occur.

5. Historical Development

Documented observations of cranial anomalies date to antiquity. Paleopathological evidence, including an Egyptian mummified anencephalic infant discovered at Hermopolis and dated to the Roman-Greco period, demonstrates historical awareness of the anomaly, where it was occasionally preserved with sacred reverence or interpreted as a zoomorphic deity resemblance.

Throughout the Middle Ages and the Renaissance, infants born with severe cranial defects were frequently framed within supernatural, astrologic, or superstitious paradigms, often termed “monsters” (from the Latin monstrare, meaning to warn or display). Early anatomical illustrations by Ambroise Paré and later Thomas Willis accurately rendered morphological representations of cranial agenesis, though pathophysiological mechanisms remained unknown.

The scientific paradigm shifted radically in the nineteenth century through the work of the French naturalists Étienne and Isidore Geoffroy Saint-Hilaire. They established teratology as an empirical discipline grounded in comparative anatomy and arrested embryonic development. In the twentieth century, embryologists including George Streeter and Douglas Padget mapped human neural tube development using the Carnegie Collection of Human Embryos, establishing precise temporal boundaries for anterior neuropore closure.

The most consequential breakthrough occurred in the mid-twentieth century through nutritional epidemiology. In 1965, British pediatrician Richard Smithells observed socioeconomic correlations with congenital anomalies, prompting investigations into nutritional deficiencies. In the late 1970s and 1980s, landmark clinical trials spearheaded by Smithells and subsequently validated by the British Medical Research Council (MRC) Vitamin Study Research Group (1991) unequivocally demonstrated that maternal consumption of folic acid during the periconceptional period reduces the incidence of neural tube defects by up to 70%. This discovery remains one of the premier triumphs of twentieth-century preventive medicine and prompted widespread mandatory food fortification initiatives across North and South America.

6. Theoretical Foundations and Pathophysiology

The pathogenesis of anencephaly is explained through integrated genetic, cellular, and biomechanical models. The leading model of neurulation in humans is the “multi-site closure model,” which suggests that neural tube closure is not a simple continuous zipper-like event, but initiates at distinct, anatomically defined focal sites before extending bidirectionally. Disruption at Site 2 (the prosencephalic-mesencephalic junction) or Site 4 (the rostral end of the neural groove) prevents anterior neuropore fusion, resulting directly in anencephaly.

At the molecular level, closure requires coordinated cell division, apical constriction, convergence and extension movements, and programmed cell death (apoptosis). The planar cell polarity (PCP) signaling pathway coordinates tissue polarity across the embryonic plane. Mutations in genes regulating the PCP pathway, including VANGL1, VANGL2, CELSR1, and FUZZY, have been implicated in animal models and human cohorts exhibiting craniorachischisis and anencephaly.

Simultaneously, one-carbon folate metabolism provides the foundational biochemical framework for normal neural crest and neuroepithelial proliferation. Folate delivers carbon units necessary for the synthesis of purines and thymidylate, vital for DNA synthesis and repair, as well as the production of S-adenosylmethionine (SAM), the primary methyl donor for epigenetic DNA and histone methylation. Impairments in enzymes such as methylenetetrahydrofolate reductase (MTHFR), methionine synthase reductase (MTRR), and reduced folate carrier 1 (RFC1) disrupt nucleotide pools and alter developmental gene expression, impairing neuroepithelial folding.

Additionally, biomechanical models show that embryonic elevation of the neural folds requires actin-myosin contraction within the apical borders of neuroepithelial cells. Any cytotoxic, metabolic, or biomechanical insult that alters cytoskeletal microfilaments, impairs cell adhesion, or increases local embryonic pressure during days 21–28 can culminate in failure of the apposing neural lips to meet and fuse.

7. Key Components, Types, and Anatomical Features

Anencephaly is categorized based on the extent of cranial vault loss and coexisting spinal defects:

• Meroanencephaly: A less extensive form characterized by rudimentary cranial bones, partial development of the skull base, and an open cranial defect where the area cerebrovasculosa is small and localized. The foramen magnum is typically intact.
• Holoanencephaly: The classical and most common variant, characterized by complete absence of the calvaria, complete exposure of the skull base, and total degeneration of both cerebral hemispheres down to the level of the brainstem.
• Craniorachischisis: The most severe manifestation of primary neural tube failure, in which anencephaly is continuous with total open dysraphism of the spinal cord (complete rachischisis). The anterior neuropore and the entire spinal neuraxis fail to close.
• Area Cerebrovasculosa: The hallmark histopathological lesion representing the degenerated, exposed embryonic brain; a vascularized mass of glial stroma, tangled choroidal vessels, cystic cavities, and sparse, disorganized neurons.
• Craniofacial Stigmata: Features include absent frontal, parietal, and squamosal bones; shallow orbits producing severe forward proptosis (the classical “frog-like” or “toad-like” facies); low-set, crumpled ears; a shortened neck; and hyperlordosis of the cervical-cranial junction.
• Neuroendocrine Disruptions: Marked hypoplasia or complete absence of the anterior and posterior pituitary glands (adenohypophysis and neurohypophysis), which causes extreme fetal adrenal gland hypoplasia due to deficient adrenocorticotropic hormone (ACTH) secretion.

8. Examples and Illustrative Cases

Clinical scenarios illustrate the presentation, diagnostic pathway, and multidisciplinary management associated with this diagnosis:

Case Example 1: Routine Second-Trimester Detection and Decision-Making

A 28-year-old primigravida presents for a routine 18-week fetal anatomy ultrasound. She had not taken periconceptional vitamin supplementation. The sonographer identifies normal lower limb anatomy, heart structure, and normal amniotic fluid levels, but cannot visualize the fetal calvaria or cerebral hemispheres above the supraorbital margin. The characteristic “frog-eye” sign is visible in the coronal plane. Maternal serum alpha-fetoprotein (MSAFP) drawn earlier that week returned at 8.4 multiples of the median (MoM), significantly elevated. After genetic counseling, fetal medicine consultation, and confirmation of isolated holoanencephaly, the patient is counseled regarding poor prognosis, palliative comfort care protocols, or voluntary termination of pregnancy, illustrating the critical role of timely prenatal screening.

Case Example 2: Term Delivery and Palliative Care Protocol

A 34-year-old multipara receives a confirmed diagnosis of meroanencephaly at 13 weeks of gestation via transvaginal ultrasonography. Due to deeply held personal values, the family opts to continue the pregnancy to term under the care of a perinatal palliative care team. The delivery occurs at 38 weeks. The infant exhibits spontaneous breathing, normal heart rate, a vigorous primitive suck reflex, and intact grasp responses. A specialized palliative care plan focusing on skin protection, warmth, non-invasive feeding, and family bonding is implemented. The infant experiences progressive bradycardia and hypothermia, dying quietly at 36 hours of life surrounded by family, exemplifying the essential role of structured palliative comfort pathways.

9. Measurement and Diagnostic Assessment

Anencephaly is among the most reliably detected fetal abnormalities. Modern obstetrical protocols identify virtually 100% of cases prior to the mid-second trimester using standard screening methodologies.

Sonography serves as the primary diagnostic imaging modality:

• First-Trimester Ultrasonography: Between weeks 11 and 13+6 days (nuchal translucency window), transvaginal or high-resolution transabdominal ultrasound detects exencephaly—the precursor lesion. Imaging reveals the “Mickey Mouse sign,” in which the bilobed, uncovered cerebral hemispheres float freely in amniotic fluid without an overlying acoustic shadow from the bony calvaria.
• Second-Trimester Ultrasonography: Following the breakdown of brain parenchyma, ultrasound confirms the absolute absence of the calvaria superior to the orbital rims. The coronal view reveals shallow orbits, known as the “frog-eye” or “frog-face” sign. Absence of the normal biparietal diameter (BPD) measurement provides definitive diagnostic confirmation.
• Biochemical Screening (Maternal Serum Alpha-Fetoprotein – MSAFP): Between 15 and 20 weeks of gestation, maternal blood is assessed for alpha-fetoprotein, an oncofetal glycoprotein synthesized by the fetal yolk sac and liver. In open neural tube defects, AFP leaks freely into the amniotic cavity through the exposed area cerebrovasculosa, diffusing across fetal membranes into maternal circulation. Values often exceed 4.0 to 10.0 MoM, providing an early biochemical indicator before ultrasound evaluation.
• Amniocentesis: In ambiguous presentations, amniocentesis evaluates amniotic fluid alpha-fetoprotein (AFAFP) and detects acetylcholinesterase (AChE) via gel electrophoresis. AChE is a specialized neural tissue enzyme whose presence in amniotic fluid confirms an open, un-epithelialized neural tube defect.
• Postnatal Physical Examination: Postnatal confirmation requires physical inspection of the cranial vault, demonstrating the absence of frontal, parietal, and squamous occipital bones, visualization of the red-purple area cerebrovasculosa, and verification of characteristic retroflexed neck positioning.

10. Clinical Applications and Practical Significance

The clinical management of anencephaly focuses primarily on secondary prevention, maternal clinical management, and postpartum comfort care:

Primary Prevention through Folic Acid Fortification: Public health policy strongly recommends that all individuals capable of becoming pregnant consume a minimum of 400 micrograms (0.4 mg) of folic acid daily starting at least one month prior to conception and continuing through the first trimester. For individuals with a prior history of a pregnancy affected by an NTD, maternal diabetes, or those taking folate-antagonist anticonvulsants (such as valproic acid or carbamazepine), the recommended dose increases tenfold to 4.0 milligrams daily. Countrywide flour and cereal fortification mandates have achieved up to 50% reductions in NTD rates worldwide.

Maternal Clinical Management: Ongoing pregnancies carrying an anencephalic fetus carry distinct maternal risks. Approximately 50% of these gestations develop severe polyhydramnios (excessive amniotic fluid volume) during the third trimester, caused by fetal inability to swallow and reabsorb amniotic fluid due to impaired brainstem swallowing centers. Polyhydramnios dramatically increases maternal risk for uterine overdistension, placental abruption, premature rupture of membranes, and postpartum hemorrhage. In addition, secondary adrenal insufficiency in the fetus often leads to absence of the hormonal cascade that triggers spontaneous labor, frequently resulting in prolonged post-term gestations that necessitate medical induction.

Perinatal Palliative Care: When a family chooses to carry an affected pregnancy to term, perinatal palliative care coordinates care plans prioritizing newborn dignity, comfort, temperature stability, and relief from distress, while avoiding invasive resuscitation, intubation, or intensive care admissions.

11. Research and Empirical Evidence

Extensive epidemiological and laboratory data document the mechanisms and trends of anencephaly:

The landmark Medical Research Council (MRC) Vitamin Study (1991), a randomized, double-blind multicenter trial across 33 centers globally, confirmed that 4 mg of folic acid daily provided a 72% protective effect against the recurrence of neural tube defects in women with prior affected pregnancies. Subsequently, Czeizel and Dudás (1992) conducted a randomized controlled trial in Hungary evaluating primary prevention using a multivitamin containing 0.8 mg of folic acid, demonstrating complete prevention of primary NTD occurrences in the supplemented cohort compared to controls.

Epidemiological registries maintained by the Centers for Disease Control and Prevention (CDC) and the European Surveillance of Congenital Anomalies (EUROCAT) have tracked the impact of mandatory national folic acid grain fortification programs. In the United States, following the 1998 FDA mandate requiring folic acid addition to enriched cereal grain products, the prevalence of anencephaly dropped by roughly 27% from 1995 to 2011, stabilizing at approximately 1 in 4,600 live births. In jurisdictions without mandatory food fortification, baseline rates remain substantially higher, varying alongside socioeconomic access, dietary patterns, and geographic altitude.

Recent molecular research led by Greene and Copp (2014) focuses on folate-resistant neural tube defects. Utilizing mouse models (such as the curly tail mutant), researchers demonstrated that cellular disruptions in the glycine cleavage system (mitochondrial folate pathway) or non-folate metabolic pathways can cause cranial neural tube failure, identifying potential alternative interventions such as inositol supplementation for high-risk maternal cohorts.

12. Cultural, Ethical, and Bioethical Considerations

Anencephaly is a central focus of modern medical ethics and bioethical philosophy:

Reproductive Autonomy and Termination: In nations with accessible reproductive healthcare, a definitive diagnosis of anencephaly frequently prompts elective termination of pregnancy, given the absolute non-viability of the fetus. However, maternal autonomous choice varies significantly based on religious beliefs, cultural norms, and local legislative restrictions. In jurisdictions with restrictive reproductive laws, patients may face legal mandates to carry non-viable pregnancies to term, raising profound debates regarding maternal psychological distress and human rights.

The Defining Threshold of Brain Death: In the late twentieth century, bioethical debates emerged regarding whether anencephalic infants could be used as living-organ donors for pediatric heart, kidney, or liver transplants. Traditional biological and legal definitions of brain death require the irreversible cessation of all functions of the entire brain, including the brainstem. Because anencephalic infants retain an intact, functioning brainstem that sustains spontaneous respiration and circulation, they do not meet whole-brain death criteria. Landmark legal cases (such as the 1992 In re T.A.C.P. case in Florida) ruled that organ procurement cannot occur until brainstem death naturally supervenes, upholding the “dead-donor rule” to protect neonatal donor interests.

Cultural Variations in Grief and Bereavement: Cultural interpretations of anencephaly vary widely. Some cultures integrate the diagnosis into broader theological frameworks of destiny or tests of faith, valuing the brief duration of the infant’s life. Neonatal palliative services worldwide have developed culturally sensitive protocols that honor family rituals, including memory-making, bereavement photography, and religious naming ceremonies.

13. Controversies, Debates, and Medical Limitations

Despite clinical consensus regarding its biological trajectory, anencephaly involves ongoing ethical and clinical debates:

Mandatory Fortification versus Consumer Autonomy: While over 80 nations have instituted mandatory folic acid fortification of staple grains, several European nations have resisted this public health measure, citing concerns over individual bodily autonomy, potential cognitive masking of vitamin B12 deficiency in elderly populations, and theoretical risks of altered methylation profiles. Epidemiologists contrast these theoretical concerns against thousands of preventable NTD-affected pregnancies each year.

Diagnostic Accuracy in Early Gestation: Very early detection of exencephaly via first-trimester ultrasound can present diagnostic ambiguity if examiners lack specialized training. Differentiating exencephaly from amniotic band syndrome or severe acrania requires clear visualization of the intact skull base and facial bones to avoid inappropriate counseling.

Invasive Interventions in Delivery: Disagreements persist regarding whether cesarean deliveries should ever be performed for an anencephalic fetus. The standard medical consensus indicates that cesarean sections should generally be avoided, as they introduce maternal surgical morbidity for a non-viable fetus. However, obstetrical emergencies such as unresolvable shoulder dystocia or severe maternal hemorrhage may warrant surgical delivery.

14. Related Terms and Differential Distinctions

Differential diagnosis and accurate classification require distinguishing anencephaly from other structural anomalies:

• Acrania: A rare malformation characterized by complete absence of the neurocranium, but unlike late anencephaly, the underlying cerebral hemispheres are fully formed and preserved without parenchymal degeneration (though acrania typically degrades into exencephaly and anencephaly over time).
• Exencephaly: The embryological precursor to anencephaly, in which the brain is fully outside the cranium but has not yet undergone maceration and destruction by amniotic fluid exposure.
• Craniorachischisis: The most extensive open NTD, characterized by anencephaly occurring concurrently with continuous open spinal dysraphism extending through the thoracic and lumbar spine.
• Encephalocele: A restricted, closed or open neural tube defect characterized by herniation of meninges and cerebral parenchyma through an isolated bony defect in the cranium (most frequently occipital), with the remainder of the skull vault fully formed.
• Amniotic Band Syndrome: An asymmetric disruption sequence where fibrous amniotic bands constrict, sever, or amputate fetal structures; when involving the skull, it produces bizarre, asymmetric cranial amputations that differ from the symmetric, midline failure characteristic of anencephaly.
• Hydranencephaly: An intracranial destructive condition where the calvaria and scalp are completely intact, but the cerebral hemispheres are largely absent and replaced by cerebrospinal fluid sacs, typically due to bilateral internal carotid artery occlusion or intrauterine infection rather than primary neurulation failure.
• Holoprosencephaly: A prosencephalic development disorder characterized by failure of the forebrain to bifurcate into two distinct cerebral hemispheres, typically presenting with an intact calvaria accompanied by severe midline facial clefting, hypotelorism, or cyclopia.

15. Summary and Key Takeaways

Anencephaly is a lethal, non-preventable once manifested, congenital neural tube defect resulting from failure of the rostral neuropore to close between embryonic days 24 and 26. This defect exposes the developing embryonic brain to amniotic fluid, leading to secondary degeneration of the cerebral hemispheres and failure of calvarial bone ossification. The diagnosis is confirmed via elevated maternal serum alpha-fetoprotein and characteristic ultrasound imaging, including absent calvaria and prominent orbits (“frog-eye sign”).

Although anencephalic infants lack higher cognitive functions, conscious perception, and neocortical integration, spontaneous brainstem activity may sustain respiration and circulatory function for hours or days after delivery. Clinical care centers on empathetic parental counseling, structured perinatal palliative care, and maternal risk mitigation regarding polyhydramnios. Periconceptional supplementation with folic acid remains the most effective, evidence-based preventive intervention, underscoring the critical value of proactive nutritional health in reproductive care.

References

• Blom, H. J., Shaw, G. M., den Heijer, M., & Finnell, R. H. (2006). Neural tube defects and folate: Case far from closed. Nature Reviews Neuroscience, 7(9), 724–731. https://doi.org/10.1038/nrn1986
• Copp, A. J., Adzick, N. S., Chitty, L. S., Fletcher, J. M., Holmbeck, G. N., & Shaw, G. M. (2015). Spina bifida. Nature Reviews Disease Primers, 1, 15007. https://doi.org/10.1038/nrdp.2015.7
• Czeizel, A. E., & Dudás, I. (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. The New England Journal of Medicine, 327(26), 1832–1835. https://doi.org/10.1056/NEJM199212243272602
• Greene, N. D., & Copp, A. J. (2014). Neural tube defects. Annual Review of Neuroscience, 37, 221–242. https://doi.org/10.1146/annurev-neuro-062012-170354
• MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. The Lancet, 338(8760), 131–137. https://doi.org/10.1016/0140-6736(91)90133-A
• Wallingford, J. B., Niswander, L. A., Shaw, G. M., & Finnell, R. H. (2013). The challenges of wiping out neural tube defects. Science, 339(6123), 1222002. https://doi.org/10.1126/science.1222002